Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities REGN - Regeneron Pharmaceuticals, Inc.
-2.2 B
LAST VALUE
-47.68%
2 YEAR CAGR
-54.24%
5 YEAR CAGR
-26.53%
10 YEAR CAGR